[26-May-2019] SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company’s HF10™ therapy for patients with chronic pain. Results will be presented at the International Neuromodulation Socie
May 26, 2019
· 5 min read